Top Employee-Paid Stories
Humira biosimilar – at 85% discount – will be sold by Mark Cuban's drug company
By Riley GriffinCoherus BioSciences will launch Yusimry – used to treat rheumatoid arthritis and psoriasis – which Cuban's Cost Plus Drugs will be offering starting in July.









